AYTU BIOPHARMA
- Pharmaceutical Preparations
- Denver, Colorado
Compensation history
Top executives at AYTU BIOPHARMA received an average of $1M per person in annual compensation from 2017 to 2023.
By year
Executives
We found ten executives who work or worked at AYTU BIOPHARMA.
Joshua Disbrow
AYTU BIOPHARMA
Chief Executive Officer
Mark Oki
AYTU BIOPHARMA
Chief Financial Officer
Greg Pyszczymuka
AYTU BIOPHARMA
Chief Commercial Officer since January
Richard Eisenstadt
AYTU BIOPHARMA
Chief Financial Officer
David Green
AYTU BIOPHARMA
Chief Financial Officer
since Green
AYTU BIOPHARMA
Chief Financial Officer
Jarrett Disbrow
AYTU BIOPHARMA
Chief Operating Officer
since Disbrow
AYTU BIOPHARMA
Chief Operating Officer
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019
About AYTU BIOPHARMA
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 7900 E. Union Avenue, Suite 920, Denver, Colorado 80237
- (720) 437-6580
- June 30
- Former names
- AYTU BIOSCIENCE, INC
- Rosewind CORP